Randhawa Simrat bought DNTH
September 23, 2025 · Form 4 insider transaction
Randhawa Simrat bought 60,000 shares of Dianthus Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderRandhawa Simrat
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 23, 2025
Filing dateSeptember 25, 2025
Shares owned after60,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after September 23, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.